GET approved for

mounjaro®

TODAY!

GET approved for

mounjaro®

TODAY!

WHAT IS Mounjaro®?

Mounjaro® (tirzepatide) is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is a dual-acting incretin mimetic that works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). GIP and GLP-1 help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.

HOW DOES Mounjaro® WORK?

Mounjaro® works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.

HOW DOES Mounjaro®
WORK?

Mounjaro® works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.

Increasing insulin secretion: Mounjaro® stimulates the release of insulin from the pancreas, which helps to lower blood sugar levels.

Slowing gastric emptying: Mounjaro® slows down the movement of food from the stomach into the small intestine, which helps you feel full for longer and eat less.

Slowing gastric emptying: Mounjaro® slows down the movement of food from the stomach into the small intestine, which helps you feel full for longer and eat less.

HOW effective is
Mounjaro®?

Mounjaro® has been shown to be effective in promoting weight loss in adults with type 2 diabetes and obesity. In one study, patients who took Mounjaro® for 84 weeks had an average weight loss of 10.2kg, compared with a weight loss of 1.2kg in patients who took a placebo. Mounjaro® was also shown to be more effective than semaglutide for weight loss.

In a research involving about 2500 patients with Mounjaro® (tirzepatide), patients on:

  • Tirzepatide 5mg: Lost 16% weight
  • Tirzepatide 10mg: Lost 21.4% weight
  • Tirzepatide 15mg: Lost 22.5% weight
  • Placebo: Lost 2.4% weight

HOW effective is
Mounjaro®?

Mounjaro® has been shown to be effective in promoting weight loss in adults with type 2 diabetes and obesity. In one study, patients who took Mounjaro® for 84 weeks had an average weight loss of 10.2kg, compared with a weight loss of 1.2kg in patients who took a placebo. Mounjaro® was also shown to be more effective than semaglutide for weight loss.

In a research involving about 2500 patients with Mounjaro® (tirzepatide), patients on:

  • Tirzepatide 5mg: Lost 16% weight
  • Tirzepatide 10mg: Lost 21.4% weight
  • Tirzepatide 15mg: Lost 22.5% weight
  • Placebo: Lost 2.4% weight

how do you take Mounjaro®?

Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.

How much to use

  • The starting dose is 2.5 mg once a week for four weeks. After four weeks your doctor will increase your dose to 5 mg once a week.

  • Your doctor may increase your dose by 2.5 mg increments to 7.5 mg, 10 mg, 12.5 mg or 15 mg once a week if you need it. In each case your doctor will tell you to stay on a particular dose for at least 4 weeks before going to a higher dose.

Do not change your dose unless your doctor has told you to.

how do you take Mounjaro®?

Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.

How much to use

  • The starting dose is 2.5 mg once a week for four weeks. After four weeks your doctor will increase your dose to 5 mg once a week.

     

  • Your doctor may increase your dose by 2.5 mg increments to 7.5 mg, 10 mg, 12.5 mg or 15 mg once a week if you need it. In each case your doctor will tell you to stay on a particular dose for at least 4 weeks before going to a higher dose.

Do not change your dose unless your doctor has told you to.

Choosing when to give
Mounjaro®?

Each pen contains one dose of Mounjaro either:

2.5mg

5mg

7.5mg

10mg

12.5mg

15mg

You can use your pen at any time of the day, with or without meals. You should use it on the same day each week if you can. To help you remember, when to use Mounjaro®, you may wish to tick the day of the week when you inject your first dose on the box that your pen comes in, or mark it on a calendar.

If necessary, you can change the day of your weekly Mounjaro® injection, as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing on that new day.

Choosing when to give
Mounjaro®?

Each pen contains one dose of Mounjaro either:

2.5mg

5mg

7.5mg

10mg

12.5mg

15mg

You can use your pen at any time of the day, with or without meals. You should use it on the same day each week if you can. To help you remember, when to use Mounjaro®, you may wish to tick the day of the week when you inject your first dose on the box that your pen comes in, or mark it on a calendar.

If necessary, you can change the day of your weekly Mounjaro® injection, as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing on that new day.

WHO QUALIFIES FOR
Mounjaro®?

Mounjaro® (tirzepatide) is a prescription medication that is used to treat adults with type 2 diabetes. It has also been licensed to be used for weight management and obesity.

To qualify for Mounjaro® for type 2 diabetes, you must:

  • Be an adult (18 years of age or older)
  • Have a diagnosis of type 2 diabetes
  • Not have had any serious allergic reactions to Mounjaro® or its ingredients

To qualify for Mounjaro® for obesity, you must:

  • Be an adult (18 years of age or older)
  • Have a body mass index (BMI) of 30 or higher
  • Have at least one weight-related health condition, such as high blood pressure, heart disease, or type 2 diabetes

WHO QUALIFIES FOR Mounjaro®?

Mounjaro® (tirzepatide) is a prescription medication that is used to treat adults with type 2 diabetes. It has also been licensed to be used for weight management and obesity.

To qualify for Mounjaro® for type 2 diabetes, you must:

  • Be an adult (18 years of age or older)
  • Have a diagnosis of type 2 diabetes
  • Not have had any serious allergic reactions to Mounjaro® or its ingredients

     

To qualify for Mounjaro® for obesity, you must:

  • Be an adult (18 years of age or older)
  • Have a body mass index (BMI) of 30 or higher
  • Have at least one weight-related health condition, such as high blood pressure, heart disease, or type 2 diabetes

HOW DOES Mounjaro®
WORK?

There are several reasons why you might not be able to take Mounjaro® (tirzepatide). Some reasons why you may not be approved for Mounjaro® could be related to your current medications, if your are pregnant or breastfeeding or your kidney function.

It is very important to undergo a medical assessment to make sure you will be 100% safe when taking Mounjaro so that you don’t suffer from any serious side effects or cause any damage to your health.

WHAT ARE THE SIDE EFFECTS?

Like all medications, there are some potential side effects from this medication. These include the following:

  • Vomiting
  • Fatigue
  • Headaches
  • Diarrhoea
  • Abdominal pain
  • Nausea
  • Constipation
  • Injection site reactions

Interested in Mounjaro®?

Please fill in all your details below to be added to our waiting list.

Request an Appointment

Please fill in all your details below.